ENDRA Life Sciences (NDRA) Other Non-Current Assets (2020 - 2026)
ENDRA Life Sciences (NDRA) reported Other Non-Current Assets of $5986.0 for Q1 2026, little changed year-over-year from $5984.0 in Q1 2025, and little changed quarter-over-quarter from $5986.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 7 years of Other Non-Current Assets data on file, last reported at $5986.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $5986.0, changed 0.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $5986.0 (changed 0.03% YoY), and the FY2025 annual result was $5986.0, down 98.36% from the prior year.
- Other Non-Current Assets steadied at $5986.0 in Q1 2026 per NDRA's latest filing, from $5986.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $647085.0 in Q1 2024 and troughed at $5984.0 in Q1 2025.
- A 5-year average of $175666.6 and a median of $5986.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets jumped 10709.97% in 2024, then slumped 99.08% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $5986.0 in 2022, then changed by 0.0% to $5986.0 in 2023, then jumped by 6004.53% to $365417.0 in 2024, then tumbled by 98.36% to $5986.0 in 2025, then changed by 0.0% to $5986.0 in 2026.
- Business Quant data shows NDRA's Other Non-Current Assets at $5986.0 in Q1 2026, $5986.0 in Q4 2025, and $365417.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 498.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 5.97 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 4.21 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 552.79 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 1.18 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 489.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 51.00 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 523.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 454.16 Mn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | 5,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,986.00 |
| Dec 31, 2025 | 5,986.00 |
| Sep 30, 2025 | 365,417.00 |
| Jun 30, 2025 | 365,417.00 |
| Mar 31, 2025 | 5,984.00 |
| Dec 31, 2024 | 365,417.00 |
| Sep 30, 2024 | 5,986.00 |
| Jun 30, 2024 | 647,085.00 |
| Mar 31, 2024 | 647,085.00 |
| Dec 31, 2023 | 5,986.00 |
| Sep 30, 2023 | 5,986.00 |
| Jun 30, 2023 | 530,068.00 |
| Mar 31, 2023 | 5,986.00 |
| Dec 31, 2022 | 5,986.00 |
| Sep 30, 2022 | 5,986.00 |
| Jun 30, 2022 | 5,986.00 |
| Mar 31, 2022 | 5,986.00 |
| Dec 31, 2021 | 5,986.00 |
| Sep 30, 2021 | 5,986.00 |
| Dec 31, 2020 | 5,986.00 |